Приказ основних података о документу

dc.creatorDobričić, Vladimir
dc.creatorSavić, Jelena
dc.creatorTomašić, Tihomir
dc.creatorDurcik, Martina
dc.creatorZidar, Nace
dc.creatorPeterlin-Mašič, Lucija
dc.creatorIlaš, Janez
dc.creatorKikelj, Danijel
dc.creatorČudina, Olivera
dc.date.accessioned2024-01-15T12:52:23Z
dc.date.available2024-01-15T12:52:23Z
dc.date.issued2024
dc.identifier.issn2083-5736
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/5431
dc.description.abstractBacterial DNA gyrase and topoisomerase IV control the topological state of DNA during replication and represent important antibacterial drug targets. To be successful as drug candidates, newly synthesized compounds must possess optimal lipophilicity, which enables efficient delivery to the site of action. In this study, retention behavior of twenty-three previously synthesized dual DNA gyrase and topoisomerase IV inhibitors was tested in RP-HPLC system, consisting of C8 column and acetonitrile/phosphate buffer (pH 5.5 and pH 7.4) mobile phase. logD was calculated at both pH values and the best correlation with logD was obtained for retention parameter φ0, indicating that this RP-HPLC system could be used as an alternative to the shake-flask determination of lipophilicity. Subsequent QSRR analysis revealed that intrinsic lipophilicity (logP) and molecular weight (bcutm13) have a positive, while solubility (bcutp3) has a negative influence on this retention parameter.sr
dc.language.isoensr
dc.publisherAkadémiai Kiadósr
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//sr
dc.relationSlovenian Research Agency (Grant No. P1-0208)sr
dc.relationThe project of bilateral cooperation between Republic of Slovenia and Republic of Serbia (BI-RS/18-19-034)sr
dc.rightsopenAccesssr
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceActa Chromatographicasr
dc.subjectRP-HPLCsr
dc.subjectDNA gyrase and topoisomerase IV inhibitorssr
dc.subjectlipophilicity predictionsr
dc.subjectPLS, MLR and SVM modelssr
dc.titleHigh-performance liquid chromatography evaluation of lipophilicity and QSRR modeling of a series of dual DNA gyrase and topoisomerase IV inhibitorssr
dc.typearticlesr
dc.rights.licenseBY-NCsr
dc.citation.volume36
dc.citation.issue1
dc.citation.spage45
dc.citation.epage51
dc.identifier.doi10.1556/1326.2022.01096
dc.identifier.scopus2-s2.0-85184057964
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/15202/High-performance_liquid_chromatography_pub_2022.pdf
dc.type.versionpublishedVersionsr


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу